Literature DB >> 24418899

Short bowel syndrome in adults: the need for an interdisciplinary approach and coordinated care.

Laura E Matarese1, Palle B Jeppesen, Stephen J D O'Keefe.   

Abstract

Short bowel syndrome (SBS) is a heterogeneous disorder with broad variation in disease severity arising from different types of intestinal resection. The spectrum of malabsorption ranges from intestinal insufficiency to intestinal failure. Individualized patient strategies involving modifications of dietary macro- and micronutrients, fluid, and pharmacologic options are required to maximize health and quality-of-life outcomes and to minimize complications and SBS-associated mortality. Intestinal rehabilitation (IR) is an established but evolving approach to improving patient outcomes by decreasing long-term dependency on parenteral support (PS) for nutrition and fluid requirements. Specialized IR programs employ team-based interdisciplinary approaches to coordinate individualized patient care and treatment management through centralized facilities. Such facilities are often specialized intestinal care centers (ICCs) established at large medical centers. A multifaceted IR program offers the comprehensive interrelated services required by patients with SBS-associated intestinal failure throughout the course of disease. Components of interdisciplinary IR programs should include medical services offering diagnostics and monitoring, pharmacologic management, and symptom and complication control; nutrition services, including dietary modifications and interventions; and supportive psychosocial and educational services. A model of care centered on the IR concept means that long-term patient management, including decisions on long-term PS, is overseen by a member of the specialized care center. Rational, seamless, and timely communication among the patient's network of home-based and ICC healthcare providers is crucial to the success of any IR program. This paradigm shift to specialized IR programs will likely result in improvements across the patient care continuum.

Entities:  

Keywords:  interdisciplinary team; intestinal failure; intestinal rehabilitation; short bowel syndrome

Mesh:

Year:  2014        PMID: 24418899     DOI: 10.1177/0148607113518946

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  5 in total

1.  Effect of Thickening Powder on Gastrointestinal Losses in Patients With High-output End Jejunostomy Syndrome - Preliminary Results.

Authors:  Zuzanna Zaczek; Karolina Dąbrowska; Mohammad Omidi; Mariusz Panczyk; Jacek Sobocki
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

Review 2.  Targeted therapy of short-bowel syndrome with teduglutide: the new kid on the block.

Authors:  Kishore Vipperla; Stephen J O'Keefe
Journal:  Clin Exp Gastroenterol       Date:  2014-12-10

3.  Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials.

Authors:  Ulrich-Frank Pape; Kishore R Iyer; Palle B Jeppesen; Marek Kunecki; Loris Pironi; Stéphane M Schneider; Douglas L Seidner; Hak-Myung Lee; John Caminis
Journal:  Therap Adv Gastroenterol       Date:  2020-04-20       Impact factor: 4.409

4.  A Single Urine Sodium Measurement May Validly Estimate 24-hour Urine Sodium Excretion in Patients With an Ileostomy.

Authors:  Anne Kathrine Nissen Pedersen; Charlotte Rud; Trine Levring Wilkens; Mette Borre; Jens Rikardt Andersen; Jens Frederik Dahlerup; Christian Lodberg Hvas
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-04-15       Impact factor: 4.016

5.  Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome.

Authors:  Lauren K Schwartz; Stephen J D O'Keefe; Ken Fujioka; Simon M Gabe; Georg Lamprecht; Ulrich-Frank Pape; Benjamin Li; Nader N Youssef; Palle B Jeppesen
Journal:  Clin Transl Gastroenterol       Date:  2016-02-04       Impact factor: 4.488

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.